Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-16 4:30 pm Purchase |
2025-04-14 | 13G | Can-Fite BioPharma Ltd. CANF |
Orca Capital AG | 375,000,000 9.700% |
375,000,000 (New Position) |
Filing History |
| 2025-02-14 5:33 pm Sale |
2024-12-31 | 13G | Can-Fite BioPharma Ltd. CANF |
Armistice Capital, LLC | 440,422 4.990% |
-238,108 (-35.09%) |
Filing History |
| 2024-11-14 4:48 pm Purchase |
2024-09-30 | 13G | Can-Fite BioPharma Ltd. CANF |
Armistice Capital, LLC | 678,530 9.990% |
24,584 (+3.76%) |
Filing History |
| 2024-02-14 3:32 pm Purchase |
2023-12-31 | 13G | Can-Fite BioPharma Ltd. CANF |
Armistice Capital, LLC | 653,946 9.990% |
653,946 (New Position) |
Filing History |
| 2022-02-14 3:23 pm Unchanged |
2021-12-31 | 13G | Can-Fite BioPharma Ltd. CANF |
CVI Investments, Inc. | 231,616,500 3.700% |
0 (Unchanged) |
Filing History |
| 2022-02-11 06:52 am Purchase |
2021-12-31 | 13G | Can-Fite BioPharma Ltd. CANF |
Mitchell P. Kopin | 394,954,370 4.990% |
65,837,870 (+20.00%) |
Filing History |
| 2022-02-04 3:59 pm Unchanged |
2021-12-31 | 13G | Can-Fite BioPharma Ltd. CANF |
Hudson Bay Capital Management LP | 243,841,500 4.080% |
0 (Unchanged) |
Filing History |
| 2021-02-16 09:54 am Sale |
2020-12-31 | 13G | Can-Fite BioPharma Ltd. CANF |
CVI Investments, Inc. | 231,616,500 5.000% |
-61,066,500 (-20.86%) |
Filing History |
| 2021-02-08 6:04 pm Purchase |
2020-12-31 | 13G | Can-Fite BioPharma Ltd. CANF |
Hudson Bay Capital Management LP | 243,841,500 5.010% |
146,341,500 (+150.09%) |
Filing History |
| 2021-01-29 06:51 am Purchase |
2020-12-31 | 13G | Can-Fite BioPharma Ltd. CANF |
Mitchell P. Kopin | 329,116,500 6.600% |
325,475,470 (+8939.10%) |
Filing History |
| 2020-06-19 4:23 pm Purchase |
2020-06-10 | 13G | Can-Fite BioPharma Ltd. CANF |
Armistice Capital, LLC | 7,199,800 4.990% |
3,292,600 (+84.27%) |
Filing History |
| 2020-06-19 06:02 am Purchase |
2020-06-10 | 13G | Can-Fite BioPharma Ltd. CANF |
CVI Investments, Inc. | 292,683,000 7.100% |
292,683,000 (New Position) |
Filing History |